In vivo magnetic resonance imaging of transgene expression.

Multifunctional magnetic nanoparticles for targeted imaging and therapy. Adv Drug Deliv Rev (2008) 3.34

Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc Natl Acad Sci U S A (2002) 3.27

Targeted and armed oncolytic poxviruses: a novel multi-mechanistic therapeutic class for cancer. Nat Rev Cancer (2009) 3.06

Magnetic nanoparticles for theragnostics. Adv Drug Deliv Rev (2009) 2.57

Ferritin as an endogenous MRI reporter for noninvasive imaging of gene expression in C6 glioma tumors. Neoplasia (2005) 2.41

Noninvasive cell-tracking methods. Nat Rev Clin Oncol (2011) 2.26

Tracking immune cells in vivo using magnetic resonance imaging. Nat Rev Immunol (2013) 2.05

Micro-NMR for rapid molecular analysis of human tumor samples. Sci Transl Med (2011) 1.96

Dextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics, and therapy. Acc Chem Res (2011) 1.93

Noninvasive real-time imaging of apoptosis. Proc Natl Acad Sci U S A (2002) 1.93

Two-step transcriptional amplification as a method for imaging reporter gene expression using weak promoters. Proc Natl Acad Sci U S A (2001) 1.85

MagA is sufficient for producing magnetic nanoparticles in mammalian cells, making it an MRI reporter. Magn Reson Med (2008) 1.76

Visualizing gene expression by whole-body fluorescence imaging. Proc Natl Acad Sci U S A (2000) 1.72

Molecular imaging in atherosclerosis, thrombosis, and vascular inflammation. Arterioscler Thromb Vasc Biol (2009) 1.65

Cellular MRI contrast via coexpression of transferrin receptor and ferritin. Magn Reson Med (2006) 1.64

Nanoscale metal-organic frameworks as potential multimodal contrast enhancing agents. J Am Chem Soc (2006) 1.61

Spatial-temporal imaging of bacterial infection and antibiotic response in intact animals. Proc Natl Acad Sci U S A (2001) 1.59

Effects of epigenetic modulation on reporter gene expression: implications for stem cell imaging. FASEB J (2005) 1.52

Accurate measurement of pancreatic islet beta-cell mass using a second-generation fluorescent exendin-4 analog. Proc Natl Acad Sci U S A (2011) 1.50

Inhibition of tumor-cell invasion with chlorotoxin-bound superparamagnetic nanoparticles. Small (2009) 1.49

The transferrin receptor: a potential molecular imaging marker for human cancer. Neoplasia (2004) 1.43

PEI-PEG-Chitosan Copolymer Coated Iron Oxide Nanoparticles for Safe Gene Delivery: synthesis, complexation, and transfection. Adv Funct Mater (2009) 1.42

Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents. Proc Natl Acad Sci U S A (2005) 1.41

Comparison of imaging techniques for tracking cardiac stem cell therapy. J Nucl Med (2007) 1.33

Imaging stem cells implanted in infarcted myocardium. J Am Coll Cardiol (2006) 1.28

Seeing stem cells at work in vivo. Stem Cell Rev (2014) 1.28

Cell tracking using magnetic resonance imaging. J Physiol (2007) 1.19

MRI reporter genes. J Nucl Med (2008) 1.19

Noninvasive monitoring of embryonic stem cells in vivo with MRI transgene reporter. Tissue Eng Part C Methods (2009) 1.19

MRI contrast agents for functional molecular imaging of brain activity. Curr Opin Neurobiol (2007) 1.15

Noninvasive imaging of pancreatic inflammation and its reversal in type 1 diabetes. J Clin Invest (2005) 1.14

Utility of a new bolus-injectable nanoparticle for clinical cancer staging. Neoplasia (2007) 1.14

Magnetic labeling of activated microglia in experimental gliomas. Neoplasia (2002) 1.11

Impact of field strength and iron oxide nanoparticle concentration on the linearity and diagnostic accuracy of off-resonance imaging. NMR Biomed (2008) 1.08

In vivo MRI of neural cell migration dynamics in the mouse brain. Neuroimage (2010) 1.08

MRI reporter genes: applications for imaging of cell survival, proliferation, migration and differentiation. NMR Biomed (2012) 1.05

Functional DNA-containing nanomaterials: cellular applications in biosensing, imaging, and targeted therapy. Acc Chem Res (2014) 1.05

MRI of transgene expression: correlation to therapeutic gene expression. Neoplasia (2002) 1.03

Nanoparticles and their applications in cell and molecular biology. Integr Biol (Camb) (2014) 1.02

Molecular Imaging of Cancer: Applications of Magnetic Resonance Methods. Proc IEEE Inst Electr Electron Eng (2005) 1.02

Pattern recognition of cancer cells using aptamer-conjugated magnetic nanoparticles. ACS Nano (2012) 1.01

In vivo detection of gene expression in liver by 31P nuclear magnetic resonance spectroscopy employing creatine kinase as a marker gene. Proc Natl Acad Sci U S A (2001) 1.01

Gene therapy imaging in patients for oncological applications. Eur J Nucl Med Mol Imaging (2005) 1.01

Nanomedicine strategies for molecular targets with MRI and optical imaging. Future Med Chem (2010) 0.99

High-performance nanostructured MR contrast probes. Nanoscale (2010) 0.98

Imaging transgene activity in vivo. Cancer Res (2008) 0.97

Nanoparticles for imaging: top or flop? Radiology (2014) 0.97

Magnetic resonance reporter gene imaging. Theranostics (2012) 0.96

In vivo serial evaluation of superparamagnetic iron-oxide labeled stem cells by off-resonance positive contrast. Magn Reson Med (2008) 0.96

Mesoporous Silica Nanoparticles with Co-Condensed Gadolinium Chelates for Multimodal Imaging. Nanomaterials (Basel) (2012) 0.95

PET-based molecular imaging in neuroscience. Eur J Nucl Med Mol Imaging (2003) 0.95

Ultrasmall, Water-Soluble Magnetite Nanoparticles with High Relaxivity for Magnetic Resonance Imaging. J Phys Chem C Nanomater Interfaces (2009) 0.94

Interaction between carbon nanotubes and mammalian cells: characterization by flow cytometry and application. Nanotechnology (2008) 0.94

Single reporter for targeted multimodal in vivo imaging. J Am Chem Soc (2012) 0.94

Noninvasive evaluation of immunosuppressive drug efficacy on acute donor cell survival. Mol Imaging Biol (2006) 0.93

Recent advances in superparamagnetic iron oxide nanoparticles for cellular imaging and targeted therapy research. Curr Pharm Des (2013) 0.92

The challenges for molecular nutrition research 2: quantification of the nutritional phenotype. Genes Nutr (2008) 0.92

Current and future technologies for breast cancer imaging. Breast Cancer Res (2001) 0.92

Advancing biomedical imaging. Proc Natl Acad Sci U S A (2015) 0.91

Magnetic nanoparticles for multi-imaging and drug delivery. Mol Cells (2013) 0.91

Multifunctional imaging nanoprobes. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2010) 0.91

Advances in using MRI probes and sensors for in vivo cell tracking as applied to regenerative medicine. Dis Model Mech (2015) 0.89

Labelling of mammalian cells for visualisation by MRI. Eur Radiol (2009) 0.88

In vivo imaging of MLC2v-luciferase, a cardiac-specific reporter gene expression in mice. Acad Radiol (2004) 0.86

A novel magnetic resonance-based method to measure gene expression in living cells. Nucleic Acids Res (2006) 0.86

Using magnetic resonance imaging and spectroscopy in cancer diagnostics and monitoring: preclinical and clinical approaches. Cancer Biol Ther (2011) 0.86

Overexpression of the MRI Reporter Genes Ferritin and Transferrin Receptor Affect Iron Homeostasis and Produce Limited Contrast in Mesenchymal Stem Cells. Int J Mol Sci (2015) 0.86

Targeted signal-amplifying enzymes enhance MRI of EGFR expression in an orthotopic model of human glioma. Cancer Res (2011) 0.85

MR-based imaging of neural stem cells. Neuroradiology (2007) 0.85

Non-invasive detection of transplanted pancreatic islets. Diabetes Obes Metab (2008) 0.85

Gravitational and magnetic field variations synergize to cause subtle variations in the global transcriptional state of Arabidopsis in vitro callus cultures. BMC Genomics (2012) 0.84

Quantitative cardiovascular magnetic resonance for molecular imaging. J Cardiovasc Magn Reson (2010) 0.84

Highly dispersible, superparamagnetic magnetite nanoflowers for magnetic resonance imaging. Chem Commun (Camb) (2009) 0.84

Developments and applications of mass microscopy. Med Mol Morphol (2010) 0.83

Non-surgical stem cell delivery strategies and in vivo cell tracking to injured myocardium. Int J Cardiovasc Imaging (2010) 0.83

Nanomedicine captures cardiovascular disease. Arterioscler Thromb Vasc Biol (2008) 0.83

Advances in cardiovascular molecular imaging for tracking stem cell therapy. Thromb Haemost (2010) 0.83

Oncolytic herpes simplex virus expressing yeast cytosine deaminase: relationship between viral replication, transgene expression, prodrug bioactivation. Cancer Gene Ther (2011) 0.82

Tumor-specific expression and detection of a CEST reporter gene. Magn Reson Med (2015) 0.82

Mesenchymal stromal cell labeling by new uncoated superparamagnetic maghemite nanoparticles in comparison with commercial Resovist--an initial in vitro study. Int J Nanomedicine (2014) 0.82

Aptamer-modified magnetic nanoprobe for molecular MR imaging of VEGFR2 on angiogenic vasculature. Nanoscale Res Lett (2013) 0.81

Gene expression and gene therapy imaging. Eur Radiol (2006) 0.81

Hierarchically-Structured Magnetic Nanoconstructs with Enhanced Relaxivity and Cooperative Tumor Accumulation. Adv Funct Mater (2014) 0.81

Detection of lysozyme magnetic relaxation switches based on aptamer-functionalized superparamagnetic nanoparticles. Anal Chem (2011) 0.80

Aptamer-nanoparticle complexes as powerful diagnostic and therapeutic tools. Exp Mol Med (2016) 0.80

Cell labeling and tracking method without distorted signals by phagocytosis of macrophages. Theranostics (2014) 0.80

Molecular imaging of pulmonary disease in vivo. Proc Am Thorac Soc (2009) 0.80

Molecular imaging in tracking tumor-specific cytotoxic T lymphocytes (CTLs). Theranostics (2014) 0.80

MRI-based detection of alkaline phosphatase gene reporter activity using a porphyrin solubility switch. Chem Biol (2014) 0.80

Metalloprotein-based MRI probes. FEBS Lett (2013) 0.79

Principles and basic concepts of molecular imaging. Pediatr Radiol (2010) 0.79

ECHO-liveFISH: in vivo RNA labeling reveals dynamic regulation of nuclear RNA foci in living tissues. Nucleic Acids Res (2015) 0.79

Development of Timd2 as a reporter gene for MRI. Magn Reson Med (2015) 0.79

Early detection of tumour immune-rejection using magnetic resonance imaging. Br J Cancer (2003) 0.78

Manufacture of IRDye800CW-coupled Fe3O4 nanoparticles and their applications in cell labeling and in vivo imaging. J Nanobiotechnology (2010) 0.78

Multimodal iron oxide nanoparticles for hybrid biomedical imaging. NMR Biomed (2012) 0.78

Genetic tools to manipulate MRI contrast. NMR Biomed (2013) 0.78

Engineering intracellular biomineralization and biosensing by a magnetic protein. Nat Commun (2015) 0.78

Bioengineered probes for molecular magnetic resonance imaging in the nervous system. ACS Chem Neurosci (2012) 0.78

Receptor imaging of pediatric tumors: clinical practice and new developments. Pediatr Radiol (2008) 0.78

In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat Biotechnol (1999) 8.46

OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat Genet (2000) 7.20

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem (1996) 6.22

Molecular imaging. Radiology (2001) 5.67

High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjug Chem (1999) 4.41

Randomized trial of group therapy for repeated deliberate self-harm in adolescents. J Am Acad Child Adolesc Psychiatry (2001) 3.89

A missense mutation in the human connexin50 gene (GJA8) underlies autosomal dominant "zonular pulverulent" cataract, on chromosome 1q. Am J Hum Genet (1998) 3.64

Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma. N Engl J Med (1994) 3.54

Diagnostic criteria for schwannomatosis. Neurology (2005) 3.41

A three-dimensional digital atlas database of the adult C57BL/6J mouse brain by magnetic resonance microscopy. Neuroscience (2005) 3.41

Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem (1984) 3.39

Differentiating human from animal isolates of Cryptosporidium parvum. Emerg Infect Dis (1999) 2.89

Connexin46 mutations in autosomal dominant congenital cataract. Am J Hum Genet (1999) 2.79

Missense mutations in MIP underlie autosomal dominant 'polymorphic' and lamellar cataracts linked to 12q. Nat Genet (2000) 2.77

Evidence that the pathway of transferrin receptor mRNA degradation involves an endonucleolytic cleavage within the 3' UTR and does not involve poly(A) tail shortening. EMBO J (1994) 2.70

Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor. Nat Genet (1996) 2.65

Prevention of vomiting after paediatric strabismus surgery: a systematic review using the numbers-needed-to-treat method. Br J Anaesth (1995) 2.49

Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses. Nat Med (1999) 2.42

Need for rigorous assessment of palliative care. BMJ (1994) 2.41

Developing a database of published reports of randomised clinical trials in pain research. Pain (1996) 2.40

Motor vehicle crashes in dementia of the Alzheimer type. Ann Neurol (1988) 2.36

Molecular characterization of Cryptosporidium isolates obtained from human immunodeficiency virus-infected individuals living in Switzerland, Kenya, and the United States. J Clin Microbiol (2000) 2.32

The use of mortality data in the report of the Resource Allocation Working Party (H.M.S.O. 1976). Public Health (1977) 2.30

Two infant vision screening programmes: prediction and prevention of strabismus and amblyopia from photo- and videorefractive screening. Eye (Lond) (1996) 2.25

Optical imaging of matrix metalloproteinase-2 activity in tumors: feasibility study in a mouse model. Radiology (2001) 2.24

Alpha-B crystallin gene (CRYAB) mutation causes dominant congenital posterior polar cataract in humans. Am J Hum Genet (2001) 2.19

Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: rescue of replication-competent virus progeny and packaging of amplicon vectors. Hum Gene Ther (1998) 2.13

In vivo imaging of proteolytic enzyme activity using a novel molecular reporter. Cancer Res (2000) 2.12

Significant event auditing. A study of the feasibility and potential of case-based auditing in primary medical care. Occas Pap R Coll Gen Pract (1995) 2.10

Properties of the mood and feelings questionnaire in adolescent psychiatric outpatients: a research note. J Child Psychol Psychiatry (1995) 1.99

Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320. Nat Cell Biol (2011) 1.98

Single-nucleotide polymorphisms can cause different structural folds of mRNA. Proc Natl Acad Sci U S A (1999) 1.97

Variation in the placebo effect in randomised controlled trials of analgesics: all is as blind as it seems. Pain (1996) 1.97

Simulated brain tumor growth dynamics using a three-dimensional cellular automaton. J Theor Biol (2000) 1.94

Treating acute pain in hospital. BMJ (1997) 1.93

Prescribing in the UK. Lancet (2001) 1.93

Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centre. AIDS (2001) 1.86

Pattern of self-organization in tumour systems: complex growth dynamics in a novel brain tumour spheroid model. Cell Prolif (2001) 1.86

National Retail Data Monitor for public health surveillance. MMWR Morb Mortal Wkly Rep (2004) 1.84

Structure and dynamics of the iron responsive element RNA: implications for binding of the RNA by iron regulatory binding proteins. J Mol Biol (1997) 1.81

Syndrome and outbreak detection using chief-complaint data--experience of the Real-Time Outbreak and Disease Surveillance project. MMWR Morb Mortal Wkly Rep (2004) 1.78

Clinical and genetic heterogeneity in autosomal dominant cataract. Br J Ophthalmol (1999) 1.77

Functional impairment of lens aquaporin in two families with dominantly inherited cataracts. Hum Mol Genet (2000) 1.73

Histology by magnetic resonance microscopy. Magn Reson Q (1993) 1.71

Anticonvulsant drugs for management of pain: a systematic review. BMJ (1995) 1.70

Farm accidents in an Irish county. J R Soc Health (1989) 1.70

Improvement of MRI probes to allow efficient detection of gene expression. Bioconjug Chem (2000) 1.70

Isolation and characterization of cDNA clones to mouse macrophage and human endothelial cell tissue transglutaminases. J Biol Chem (1991) 1.60

Synergistic anticancer effects of ganciclovir/thymidine kinase and 5-fluorocytosine/cytosine deaminase gene therapies. J Natl Cancer Inst (1998) 1.60

Clonal analysis of the microbiota of severe early childhood caries. Caries Res (2010) 1.59

Electrolyte pH changes in Human Milk. Pediatr Res (1977) 1.59

Implanon. A review of clinical studies. Br J Fam Plann (1999) 1.58

Preparation of a cathepsin D sensitive near-infrared fluorescence probe for imaging. Bioconjug Chem (1999) 1.56

Evaluation of syndromic surveillance systems--design of an epidemic simulation model. MMWR Morb Mortal Wkly Rep (2004) 1.54

Complement depletion facilitates the infection of multiple brain tumors by an intravascular, replication-conditional herpes simplex virus mutant. J Virol (2000) 1.54

Single dose oral paracetamol (acetaminophen) for postoperative pain. Cochrane Database Syst Rev (2004) 1.54

Positron emission tomography in Alzheimer's disease. Neurology (1986) 1.52

Controlled trial of a brief cognitive-behavioural intervention in adolescent patients with depressive disorders. J Child Psychol Psychiatry (1996) 1.49

Randomization is important in studies with pain outcomes: systematic review of transcutaneous electrical nerve stimulation in acute postoperative pain. Br J Anaesth (1996) 1.49

MR imaging of gene delivery to the central nervous system with an artificial vector. Radiology (1998) 1.49

Human transferrin receptor gene as a marker gene for MR imaging. Radiology (2001) 1.48

Buprenorphine kinetics. Clin Pharmacol Ther (1980) 1.47

An infectious transfer and expression system for genomic DNA loci in human and mouse cells. Nat Biotechnol (2001) 1.46

Congenital progressive polymorphic cataract caused by a mutation in the major intrinsic protein of the lens, MIP (AQP0). Br J Ophthalmol (2000) 1.45

Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome. Mol Ther (2001) 1.45

Upper limb musculoskeletal disorders in highly repetitive industries: precise anatomical physical findings. Ergonomics (1995) 1.44

Comparison of 3-D maximum a posteriori and filtered backprojection algorithms for high-resolution animal imaging with microPET. IEEE Trans Med Imaging (2000) 1.44

SOX2 anophthalmia syndrome: 12 new cases demonstrating broader phenotype and high frequency of large gene deletions. Br J Ophthalmol (2007) 1.44

Single-step conversion of cells to retrovirus vector producers with herpes simplex virus-Epstein-Barr virus hybrid amplicons. J Virol (1999) 1.43

Quantitative CT analysis of brain morphometry in adult Down's syndrome at different ages. Neurology (1987) 1.43

Nervous system defects of AnkyrinB (-/-) mice suggest functional overlap between the cell adhesion molecule L1 and 440-kD AnkyrinB in premyelinated axons. J Cell Biol (1998) 1.43

Iron and sudden infant death syndrome. BMJ (1989) 1.42

A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy. Epilepsy Res (1997) 1.42

Frequency and spatial distribution of environmental Campylobacter spp. Appl Environ Microbiol (2004) 1.42

Effect of visualization display colour on polyp conspicuity at virtual colonoscopy. Clin Radiol (2008) 1.39

Anxiety, vocalization, and agitation following peripheral nerve block with ropivacaine. Reg Anesth Pain Med (1999) 1.39

In vivo reflectance confocal microscopy of shave biopsy wounds: feasibility of intraoperative mapping of cancer margins. Br J Dermatol (2010) 1.39

A novel index for predicting intraocular pressure reduction following cataract surgery. Br J Ophthalmol (2005) 1.38

Midazolam infusion in a pediatric intensive care unit. Ann Pharmacother (1993) 1.38

Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer. J Clin Oncol (2001) 1.35

Normal cortisol response to corticotropin in patients with secondary adrenal failure. Arch Intern Med (1983) 1.31

A biotechnological approach to improving the nutritive value of alfalfa. J Anim Sci (1995) 1.31

Effects of innate immunity on herpes simplex virus and its ability to kill tumor cells. Gene Ther (2003) 1.31

Measuring transferrin receptor gene expression by NMR imaging. Biochim Biophys Acta (1998) 1.31

Inhibition of IL-12 production in human monocyte-derived macrophages by TNF. J Immunol (2000) 1.30

Development of a rapid method to generate multiple oncolytic HSV vectors and their in vivo evaluation using syngeneic mouse tumor models. Gene Ther (2006) 1.29

Anticonvulsant drugs for acute and chronic pain. Cochrane Database Syst Rev (2005) 1.27

Cell cycle-dependent phosphorylation of human DNA polymerase alpha. J Biol Chem (1991) 1.27

MicroRNAs and glioblastoma; the stem cell connection. Cell Death Differ (2009) 1.27

Recurrent 17 bp duplication in PITX3 is primarily associated with posterior polar cataract (CPP4). J Med Genet (2004) 1.27

Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapy. Hum Gene Ther (1997) 1.26

Levels of zoonotic agents in British livestock manures. Lett Appl Microbiol (2004) 1.26

No evidence for infection of human cells with porcine endogenous retrovirus (PERV) after exposure to porcine fetal neuronal cells. Transplantation (2000) 1.25

Macrocyclic chelators with paramagnetic cations are internalized into mammalian cells via a HIV-tat derived membrane translocation peptide. Bioconjug Chem (2000) 1.25

Activins, inhibins, and follistatins: further thoughts on a growing family of regulators. Proc Soc Exp Biol Med (1997) 1.21

Progesterone assays: guidelines for the provision of a clinical biochemistry service. Ann Clin Biochem (1985) 1.19

Analyses of livestock production, waste storage, and pathogen levels and prevalences in farm manures. Appl Environ Microbiol (2005) 1.18

Propofol anaesthesia and postoperative nausea and vomiting: quantitative systematic review of randomized controlled studies. Br J Anaesth (1997) 1.18

B-myb promoter retargeting of herpes simplex virus gamma34.5 gene-mediated virulence toward tumor and cycling cells. J Virol (1999) 1.18